Adama will license Australian company Starpharma’s Priostar dendrimer technology for the development and commercialization of an enhanced, proprietary 2,4-D herbicide for the U.S. market, the companies announced.
2014年美国2,4-D市场价值约为$1.15亿美元，美国农业部预计到2020年将增长70%以上。
Adama 已经开始开发一种包含 Priostar 树枝状聚合物技术的新颖独特的 2,4-D 产品，该产品有望为种植者提供更好的灵活性和杂草控制优势，并提高安全性。这将允许按目标应用，从而通过减少所需产品的数量来有益于环境。
Sami Shabtai, Head of Innovative Development at Adama, commented, “As a farmer-centric company, Adama constantly strives to bring new and innovative solutions to farmers that will simplify their lives. The innovative nature and superior performance of the Priostar formulations fit well with our strategy to deliver simple and efficient solutions to farmers to help them grow. This is yet another step in the evolution and differentiation of our offering, as we continue to introduce unique mixtures and formulations to the market.”
Dr. Jackie Fairley, CEO of Starpharma, said, “We enjoy a positive relationship with Adama, and their extensive trials of Priostar-improved 2,4-D formulations have led to this license agreement. With Adama’s strong, proven record of innovative product development, we are very pleased to have them as commercial partners for Priostar-improved 2,4-D products. In addition, we continue to explore other Priostar product opportunities with Adama.”